Novo Nordisk Introduces Daily Wegovy Pill Amid Price Competition
TL;DR Summary
Americans can now access a daily pill form of Wegovy, a popular weight-loss drug, which is generally cheaper than the weekly injection and is available with a prescription. The pill contains the same active ingredient as the injection, semaglutide, and offers an alternative for those seeking weight management solutions, with pricing options and insurance savings programs. The FDA approved the oral version in late December, and it shows similar efficacy and side effects to the injectable form.
- Starter dose of Wegovy now available as a daily pill instead of weekly injection CNN
- First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. CNBC
- A Pill Version of Wegovy Hits Pharmacies Time Magazine
- What to watch for in weight loss drugs in 2026: Price changes, GLP-1 pills and more NBC News
- Novo Nordisk launches price war over weight-loss pills Financial Times
Reading Insights
Total Reads
0
Unique Readers
5
Time Saved
3 min
vs 4 min read
Condensed
88%
654 → 77 words
Want the full story? Read the original article
Read on CNN